Selective sigma receptor agonist 2-(4-morpholinethyl)1-phenylcyclohexanecarboxylate (PRE084) promotes neuroprotection and neurite elongation through protein kinase C (PKC) signaling on motoneurons

Neuroscience

Volumn 162, Issue 1, 2009, Pages 31-38

  Guzman Lenis M S ^a,b   Navarro, X ^a,b   Casas, C ^a,b  

^a Institute of Neuroscience   (Spain)

^b CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED SOBRE ENFERMEDADES NEURODEGENERATIVAS CIBERNED   (Spain)

Author keywords

excitotoxicity; motoneuron; neurite elongation; neuroprotection; organotypic culture; spinal cord injury

Indexed keywords

1 PHENYLCYCLOHEXANECARBOXYLIC ACID 2 MORPHOLINOETHYL ESTER; CHELERYTHRINE; GLUTAMIC ACID; OPIATE AGONIST; OPIATE ANTAGONIST; PROTEIN KINASE C; SIGMA OPIATE RECEPTOR;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; EXCITOTOXICITY; EXPLANT; IMMUNOHISTOCHEMISTRY; MOTONEURON; NERVE CELL; NERVE FIBER GROWTH; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; SPINAL CORD; SPINAL CORD LESION; SPINAL GANGLION; TISSUE SLICE;

EID: 67349112448     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2009.03.067     Document Type: Article

References (49)

1. Adamchik Y., Frantseva M.V., Weisspapir M., Carlen P.L., and Perez Velazquez J.L. Methods to induce primary and secondary traumatic damage in organotypic hippocampal slice cultures. Brain Res Brain Res Protoc 5 (2000) 153-158
2. Alonso G., Phan V., Guillemain I., Saunier M., Legrand A., Anoal M., and Maurice T. Immunocytochemical localization of the sigma (1) receptor in the adult rat central nervous system. Neuroscience 97 (2000) 155-170
3. Aydar E., Palmer C.P., Klyachko V.A., and Jackson M.B. The sigma receptor as a ligand-regulated auxiliary potassium channel subunit. Neuron 34 (2002) 399-410
4. Collazos-Castro J.E., Soto V.M., Gutierrez-Davila M., and Nieto-Sampedro M. Motoneuron loss associated with chronic locomotion impairments after spinal cord contusion in the rat. J Neurotrauma 22 (2005) 544-558
5. Cordey M., and Pike C.J. Conventional protein kinase C isoforms mediate neuroprotection induced by phorbol ester and estrogen. J Neurochem 96 (2006) 204-217
6. DeCoster M.A., Klette K.L., Knight E.S., and Tortella F.C. Sigma receptor-mediated neuroprotection against glutamate toxicity in primary rat neuronal cultures. Brain Res 671 (1995) 45-53
7. Deister C., and Schmidt C.E. Optimizing neurotrophic factor combinations for neurite outgrowth. J Neural Eng 3 (2006) 172-179
8. Felipo V., Minana M.D., and Grisolia S. Inhibitors of protein kinase C prevent the toxicity of glutamate in primary neuronal cultures. Brain Res 609 (1993) 192-196
9. Garcia-Alias G., Valero-Cabre A., Lopez-Vales R., Fores J., Verdu E., and Navarro X. Differential motor and electrophysiological outcome in rats with mid-thoracic or high lumbar incomplete spinal cord injuries. Brain Res 1108 (2006) 195-204
10. Glazer A.N., Peck K., and Mathies R.A. A stable double-stranded DNA-ethidium homodimer complex: application to picogram fluorescence detection of DNA in agarose gels. Proc Natl Acad Sci U S A 87 (1990) 3851-3855
11. Goyagi T., Bhardwaj A., Koehler R.C., Traystman R.J., Hurn P.D., and Kirsch J.R. Potent sigma 1-receptor ligand 4-phenyl-1-(4-phenylbutyl) piperidine provides ischemic neuroprotection without altering dopamine accumulation in vivo in rats. Anesth Analg 96 (2003) 532-538 table of contents
12. Goyagi T., Goto S., Bhardwaj A., Dawson V.L., Hurn P.D., and Kirsch J.R. Neuroprotective effect of sigma(1)-receptor ligand 4-phenyl-1-(4-phenylbutyl) piperidine (PPBP) is linked to reduced neuronal nitric oxide production. Stroke 32 (2001) 1613-1620
13. Guzman-Lenis M.S., Vallejo C., Navarro X., and Casas C. Analysis of FK506-mediated protection in an organotypic model of spinal cord damage: Heat shock protein 70 levels are modulated in microglial cells. Neuroscience 155 (2008) 104-113
14. Han Y.S., Zheng W.H., Bastianetto S., Chabot J.G., and Quirion R. Neuroprotective effects of resveratrol against beta-amyloid-induced neurotoxicity in rat hippocampal neurons: involvement of protein kinase C. Br J Pharmacol 141 (2004) 997-1005
15. Harukuni I., Bhardwaj A., Shaivitz A.B., DeVries A.C., London E.D., Hurn P.D., Traystman R.J., Kirsch J.R., and Faraci F.M. Sigma(1)-receptor ligand 4-phenyl-1-(4-phenylbutyl)-piperidine affords neuroprotection from focal ischemia with prolonged reperfusion. Stroke 31 (2000) 976-982
16. ++ mobilization by N-methyl-D-aspartate in primary culture of rat frontal cortical neurons. J Pharmacol Exp Ther 275 (1995) 207-214
17. Hayashi T., Maurice T., and Su T.P. Ca(2+) signaling via sigma(1)-receptors: novel regulatory mechanism affecting intracellular Ca(2+) concentration. J Pharmacol Exp Ther 293 (2000) 788-798
18. Hayashi T., and Su T.P. Sigma-1 receptor chaperones at the ER-mitochondrion interface regulate Ca(2+) signaling and cell survival. Cell 131 (2007) 596-610
19. Hayashi T., and Su T.P. Regulating ankyrin dynamics: roles of sigma-1 receptors. Proc Natl Acad Sci U S A 98 (2001) 491-496
20. Hong W., Nuwayhid S.J., and Werling L.L. Modulation of bradykinin-induced calcium changes in SH-SY5Y cells by neurosteroids and sigma receptor ligands via a shared mechanism. Synapse 54 (2004) 102-110
21. Jung Y.S., Lee B.K., Park H.S., Shim J.K., Kim S.U., Lee S.H., Baik E.J., and Moon C.H. Activation of protein kinase C-delta attenuates kainate-induced cell death of cortical neurons. Neuroreport 16 (2005) 741-744
22. Klette K.L., Lin Y., Clapp L.E., DeCoster M.A., Moreton J.E., and Tortella F.C. Neuroprotective sigma ligands attenuate NMDA and trans-ACPD-induced calcium signaling in rat primary neurons. Brain Res 756 (1997) 231-240
23. Kosacka J., Figiel M., Engele J., Hilbig H., Majewski M., and Spanel-Borowski K. Angiopoietin-1 promotes neurite outgrowth from dorsal root ganglion cells positive for tie-2 receptor. Cell Tissue Res 320 (2005) 11-19
24. Lafon-Cazal M., Pietri S., Culcasi M., and Bockaert J. NMDA-dependent superoxide production and neurotoxicity. Nature 364 (1993) 535-537
25. Lipton S.A., and Rosenberg P.A. Excitatory amino acids as a final common pathway for neurologic disorders. N Engl J Med 330 (1994) 613-622
26. Liu D., Thangnipon W., and McAdoo D.J. Excitatory amino acids rise to toxic levels upon impact injury to the rat spinal cord. Brain Res 547 (1991) 344-348
27. Lu J., Ashwell K.W., and Waite P. Advances in secondary spinal cord injury: role of apoptosis. Spine 25 (2000) 1859-1866
28. McAdoo D.J., Xu G.Y., Robak G., and Hughes M.G. Changes in amino acid concentrations over time and space around an impact injury and their diffusion through the rat spinal cord. Exp Neurol 159 (1999) 538-544
29. McCann D.J., and Su T.P. Haloperidol-sensitive (+) [3H]SKF-10,047 binding sites (sigma sites) exhibit a unique distribution in rat brain subcellular fractions. Eur J Pharmacol 188 (1990) 211-218
30. 2+: clinical and therapeutic relevance. Biol Cell 97 (2005) 873-883
31. Monnet F.P., Morin-Surun M.P., Leger J., and Combettes L. Protein kinase C-dependent potentiation of intracellular calcium influx by sigma1 receptor agonists in rat hippocampal neurons. J Pharmacol Exp Ther 307 (2003) 705-712
32. Nakajima H., Uchida K., Kobayashi S., Inukai T., Horiuchi Y., Yayama T., Sato R., and Baba H. Rescue of rat anterior horn neurons after spinal cord injury by retrograde transfection of adenovirus vector carrying brain-derived neurotrophic factor gene. J Neurotrauma 24 (2007) 703-712
33. Nishimura T., Ishima T., Iyo M., and Hashimoto K. Potentiation of nerve growth factor-induced neurite outgrowth by fluvoxamine: role of sigma-1 receptors, IP3 receptors and cellular signaling pathways. PLoS ONE 3 (2008) e2558
34. 3H]dopamine release is dependent upon protein kinase C. J Pharmacol Exp Ther 304 (2003) 364-369
35. Rothstein J.D., Jin L., Dykes-Hoberg M., and Kuncl R.W. Chronic inhibition of glutamate uptake produces a model of slow neurotoxicity. Proc Natl Acad Sci U S A 90 (1993) 6591-6595
36. Sekhon L.H., and Fehlings M.G. Epidemiology, demographics, and pathophysiology of acute spinal cord injury. Spine 26 (2001) S2-S12
37. Senda T., Mita S., Kaneda K., Kikuchi M., and Akaike A. Effect of SA4503, a novel sigma1 receptor agonist, against glutamate neurotoxicity in cultured rat retinal neurons. Eur J Pharmacol 342 (1998) 105-111
38. Su T.P., and Hayashi T. Understanding the molecular mechanism of sigma-1 receptors: towards a hypothesis that sigma-1 receptors are intracellular amplifiers for signal transduction. Curr Med Chem 10 (2003) 2073-2080
39. Takahashi H., Kirsch J.R., Hashimoto K., London E.D., Koehler R.C., and Traystman R.J. PPBP [4-phenyl-1-(4-phenylbutyl) piperidine], a potent sigma-receptor ligand, decreases brain injury after transient focal ischemia in cats. Stroke 26 (1995) 1676-1682
40. Takebayashi M., Hayashi T., and Su T.P. Nerve growth factor-induced neurite sprouting in PC12 cells involves sigma-1 receptors: implications for antidepressants. J Pharmacol Exp Ther 303 (2002) 1227-1237
41. Tchedre K.T., and Yorio T. Sigma-1 receptors protect RGC-5 cells from apoptosis by regulating intracellular calcium, bax levels, and caspase-3 activation. Invest Ophthalmol Vis Sci 49 (2008) 2577-2588
42. Teng Y.D., Mocchetti I., Taveira-DaSilva A.M., Gillis R.A., and Wrathall J.R. Basic fibroblast growth factor increases long-term survival of spinal motor neurons and improves respiratory function after experimental spinal cord injury. J Neurosci 19 (1999) 7037-7047
43. Tomimatsu N., and Arakawa Y. Protein kinase C-mediated protection of motoneurons from excitotoxicity. Neurosci Lett 439 (2008) 143-146
44. Urushitani M., Shimohama S., Kihara T., Sawada H., Akaike A., Ibi M., Inoue R., Kitamura Y., Taniguchi T., and Kimura J. Mechanism of selective motor neuronal death after exposure of spinal cord to glutamate: involvement of glutamate-induced nitric oxide in motor neuron toxicity and nonmotor neuron protection. Ann Neurol 44 (1998) 796-807
45. Vajda F.J. Neuroprotection and neurodegenerative disease. J Clin Neurosci 9 (2002) 4-8
46. Wagey R., Hu J., Pelech S.L., Raymond L.A., and Krieger C. Modulation of NMDA-mediated excitotoxicity by protein kinase C. J Neurochem 78 (2001) 715-726
47. Yoshioka A., Yamaya Y., Saiki S., Kanemoto M., Hirose G., and Pleasure D. Cyclic GMP/cyclic GMP-dependent protein kinase system prevents excitotoxicity in an immortalized oligodendroglial cell line. J Neurochem 74 (2000) 633-640
48. Yu R., Mandlekar S., Tan T.H., and Kong A.N. Activation of p38 and c-Jun N-terminal kinase pathways and induction of apoptosis by chelerythrine do not require inhibition of protein kinase C. J Biol Chem 275 (2000) 9612-9619
49. Zhang B., Yang L., Konishi Y., Maeda N., Sakanaka M., and Tanaka J. Suppressive effects of phosphodiesterase type IV inhibitors on rat cultured microglial cells: comparison with other types of cAMP-elevating agents. Neuropharmacology 42 (2002) 262-269